NO884795L - Rekombinant, humant immunoglobulin og fremgangsmaate for fremstilling av dette. - Google Patents

Rekombinant, humant immunoglobulin og fremgangsmaate for fremstilling av dette.

Info

Publication number
NO884795L
NO884795L NO88884795A NO884795A NO884795L NO 884795 L NO884795 L NO 884795L NO 88884795 A NO88884795 A NO 88884795A NO 884795 A NO884795 A NO 884795A NO 884795 L NO884795 L NO 884795L
Authority
NO
Norway
Prior art keywords
recombinant
preparing
procedure
human immunoglobulin
immunoglobulin
Prior art date
Application number
NO88884795A
Other languages
English (en)
Other versions
NO884795D0 (no
Inventor
Linda J Harris
Leah A Lipsich
Michael A Walls
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of NO884795D0 publication Critical patent/NO884795D0/no
Publication of NO884795L publication Critical patent/NO884795L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO88884795A 1987-10-28 1988-10-27 Rekombinant, humant immunoglobulin og fremgangsmaate for fremstilling av dette. NO884795L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11463287A 1987-10-28 1987-10-28
US25400488A 1988-09-16 1988-09-16

Publications (2)

Publication Number Publication Date
NO884795D0 NO884795D0 (no) 1988-10-27
NO884795L true NO884795L (no) 1989-04-28

Family

ID=26812406

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88884795A NO884795L (no) 1987-10-28 1988-10-27 Rekombinant, humant immunoglobulin og fremgangsmaate for fremstilling av dette.

Country Status (10)

Country Link
EP (1) EP0314161A1 (no)
JP (1) JPH02138989A (no)
AU (2) AU634151B2 (no)
DK (1) DK597288A (no)
FI (1) FI884924A (no)
IL (1) IL88175A0 (no)
MY (1) MY104344A (no)
NO (1) NO884795L (no)
NZ (1) NZ226694A (no)
PT (1) PT88874B (no)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63267295A (ja) * 1986-12-03 1988-11-04 Sumitomo Chem Co Ltd ヒト抗体、抗体遺伝子及び対応する組換え体
US5610034A (en) * 1987-04-29 1997-03-11 Alko Group Ltd. Immunoglobulin production by trichoderma
CA2066720A1 (en) * 1989-09-19 1991-03-20 David M. Knight Method for improving human monoclonal antibody production
JPH04505709A (ja) * 1989-11-07 1992-10-08 ブリストル―マイアーズ　スクイブ　カンパニー オリゴマー免疫グロブリン
CA2084189A1 (en) * 1990-07-16 1992-01-17 Alko Group Limited Immunoglobulin production by trichoderma
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
TW373023B (en) * 1991-07-15 1999-11-01 Wellcome Found Production of antibodies
CA2078539C (en) * 1991-09-18 2005-08-02 Kenya Shitara Process for producing humanized chimera antibody
US6042828A (en) 1992-09-07 2000-03-28 Kyowa Hakko Kogyo Co., Ltd. Humanized antibodies to ganglioside GM2
US5939532A (en) * 1993-09-07 1999-08-17 Kyowa Hakko Kogyo Co., Ltd Humanized antibodies to ganglioside GM2
EP0598998B1 (en) * 1992-09-07 2004-05-19 Kyowa Hakko Kogyo Co., Ltd Humanized antibodies reacting with the ganglioside GM2
US6130364A (en) * 1995-03-29 2000-10-10 Abgenix, Inc. Production of antibodies using Cre-mediated site-specific recombination
ATE469217T1 (de) 2000-08-11 2010-06-15 Kyowa Hakko Kirin Co Ltd Den phosphorsäure-metabolismus, den kalzium- metabolismus, verkalkung und den vitamin d- metabolismus kontrollierende polypeptide sowie für diese kodierende dna-moleküle
EP2011802A3 (en) 2001-04-27 2009-04-15 Kyowa Hakko Kirin Co., Ltd. Anti-CD40 monoclonal antibody
KR101016476B1 (ko) 2001-12-28 2011-02-24 교와 핫꼬 기린 가부시키가이샤 섬유아세포 증식 인자-23에 대한 항체
ES2368733T3 (es) 2002-07-18 2011-11-21 Merus B.V. Producción recombinante de mezclas de anticuerpos.
USRE47770E1 (en) 2002-07-18 2019-12-17 Merus N.V. Recombinant production of mixtures of antibodies
CA2527694C (en) 2003-05-30 2015-07-14 Hendricus Renerus Jacobus Mattheus Hoogenboom Fab library for the preparation of anti vegf and anti rabies virus fabs
US20100069614A1 (en) 2008-06-27 2010-03-18 Merus B.V. Antibody producing non-human mammals
JP4242388B2 (ja) 2003-12-25 2009-03-25 協和発酵キリン株式会社 抗ｃｄ４０抗体の変異体
CA2554054C (en) 2004-01-20 2013-06-04 Merus B.V. Mixtures of binding proteins
KR100918746B1 (ko) 2004-09-06 2009-09-24 교와 핫꼬 기린 가부시키가이샤 항 ａ３３ 항체
EP2006380A4 (en) 2006-03-23 2010-08-11 Kyowa Hakko Kirin Co Ltd AGONIST ANTIBODY AGAINST THE HUMAN THROMBOPOIETINE RECEPTOR
TWI390034B (zh) 2006-04-06 2013-03-21 Kyowa Hakko Kirin Co Ltd Novel anti-CD98 antibody
GB0700133D0 (en) 2007-01-04 2007-02-14 Humabs Llc Human cytomegalovirus neutralising antibodies and use thereof
US7947274B2 (en) 2007-01-04 2011-05-24 Humabs, LLC. Human cytomegalovirus neutralising antibodies and use thereof
US7883705B2 (en) 2007-02-14 2011-02-08 Kyowa Hakko Kirin Co., Ltd. Anti FGF23 antibody and a pharmaceutical composition comprising the same
CN106924729B (zh) 2008-07-16 2021-03-02 生物医学研究学会 人巨细胞病毒中和抗体及其应用
KR102382304B1 (ko) 2012-04-20 2022-04-04 메뤼스 엔.페. Ig-유사 분자의 제조방법 및 제조수단
CN104736174B (zh) 2012-07-06 2019-06-14 根马布私人有限公司 具有三重突变的二聚体蛋白质
HUE026516T2 (en) * 2012-09-24 2016-06-28 Lonza Biologics Plc Expression vectors containing chimeric cytomegalovirus promoter and enhancer sequences
CN105051066B (zh) 2012-09-27 2019-08-06 美勒斯公司 作为T细胞衔接器的双特异性IgG抗体
AU2015223566B2 (en) 2014-02-28 2020-10-08 Merus N.V. Antibodies that bind EGFR and ErbB3
SI3110849T1 (sl) 2014-02-28 2021-01-29 Merus N.V. Protitelo, ki veže ERBB-2 in ERBB-3
LT3115376T (lt) 2015-07-10 2018-11-12 Merus N.V. Antikūnai, kurie jungiasi su žmogaus cd3
SI3365373T1 (sl) 2015-10-23 2021-08-31 Merus N.V. Vezne molekule, ki zaviranjo rast raka
WO2018182422A1 (en) 2017-03-31 2018-10-04 Merus N.V. Erbb-2 and erbb3 binding bispecific antibodies for use in the treatment f cells that have an nrg1 fusion gene
SG11202001050PA (en) 2017-08-09 2020-03-30 Merus Nv Antibodies that bind egfr and cmet
EP3693013A4 (en) 2017-10-06 2021-06-30 Ono Pharmaceutical Co., Ltd. BISPECIFIC ANTIBODY
TWI804572B (zh) 2018-02-09 2023-06-11 日商小野藥品工業股份有限公司 雙特異性抗體
TW202102544A (zh) 2019-04-04 2021-01-16 日商小野藥品工業股份有限公司 雙特異性抗體
TWI809286B (zh) 2019-07-05 2023-07-21 日商小野藥品工業股份有限公司 以pd-1/cd3雙特異性蛋白質所進行之血液性癌症治療
JP6856183B1 (ja) 2019-07-30 2021-04-07 小野薬品工業株式会社 二重特異性抗体
JPWO2021025140A1 (no) 2019-08-08 2021-02-11

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
AU606320B2 (en) * 1985-11-01 1991-02-07 International Genetic Engineering, Inc. Modular assembly of antibody genes, antibodies prepared thereby and use

Also Published As

Publication number Publication date
PT88874B (pt) 1994-01-31
FI884924A (fi) 1989-04-29
JPH02138989A (ja) 1990-05-28
FI884924A0 (fi) 1988-10-25
IL88175A0 (en) 1989-06-30
AU2436388A (en) 1989-06-01
PT88874A (pt) 1989-07-31
NO884795D0 (no) 1988-10-27
AU634151B2 (en) 1993-02-18
DK597288A (da) 1989-04-29
DK597288D0 (da) 1988-10-27
NZ226694A (en) 1994-04-27
EP0314161A1 (en) 1989-05-03
AU2608292A (en) 1992-12-17
MY104344A (en) 1994-03-31

Similar Documents

Publication Publication Date Title
NO884795L (no) Rekombinant, humant immunoglobulin og fremgangsmaate for fremstilling av dette.
NO872729D0 (no) Cefalosporinhydrat og fremgangsmaate for dets fremstilling.
NO871025D0 (no) Polypeptid, dna og fremgangsmaate for fremstilling derav.
NO884733D0 (no) Roermuffe og fremgangsmaate til fremstilling av samme.
NO853120L (no) Isfjell og fremgangsmaate for fremstilling av samme.
NO882766L (no) Katalysatorer og fremgangsmaate for deres fremstilling.
NO855026L (no) Aminoacyllabdaner og fremgangsmaate til fremstilling derav.
DK169987D0 (da) Human tumor-associated antigen, ca-ou1
NO864194D0 (no) Slipekorn og fremgangsmaate til fremstilling derav.
NO901745D0 (no) Fremgangsmaate og system for aa gjennomfoere minesveiping.
DK103889D0 (da) Benzimidazooe1,2-caachinazoliner og fremgangsmaade til fremstilling heraf
DE3853743T2 (de) Rekombinanter menschlicher ADF.
NO870210D0 (no) Fremgangsmaate og anordning for avskinning.
NO873197D0 (no) Bedoevelsespreparat og fremgangsmaate for anvendelse av dette.
NO872587D0 (no) Forbedret limpreparat og fremgangsmaate for fremstilling av dette.
NO880292D0 (no) Fremgangsmaate for behandling av humle.
NO881713L (no) Fremgangsmaate for fremstilling av di-t-butylfenyl-alkyl og benzylethere.
NO853519L (no) Tannpleiemiddel og fremgangsmaate for fremstilling av dette.
NO912192D0 (no) Rekombinante dna og fremgangsmaate for fremstilling av chimere antistoffer.
NO157842C (no) Engangshanske og fremgangsmaate for fremstilling av samme.
NO845134L (no) Dialkanoyloksybenzyliden-dialkanoat og fremgangsmaate til fremstilling derav.
NO872765L (no) Beta-laktam-sammensetning, og framgangsmaate for framstilling av denne.
NO883363D0 (no) Nytt diosminderivat og fremgangsmaate for fremstilling av dette.
NO873274L (no) Tettet roerskjoet og fremgangsmaate for dannelse av denne.
IT8720970A0 (it) Procedimento per preparare carnitossi-carnitina e acetilcarnitossi-carnitina.